| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |